Evidence map›Paper›PMID 11854191›Full record

ArticleInfection and immunity2002

Characterization of a cytotoxic factor in culture filtrates of Serratia marcescens.

Kent B Marty, Christopher L Williams, Linda J Guynn, Michael J Benedik, Steven R Blanke

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
0.6field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 54 citations in OpenAlex.

  1. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
  2. Article
  3. Review
  4. Increased Proteolytic Activity ofPolish journal of microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Structure of a thermostable serralysin from Serratia sp. FS14 at 1.1 Å resolution.Acta crystallographica. Section F, Structural biology communications · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kent B MartyDepartment of Biology and Biochemistry, University of Houston, Houston, Texas 77204-5001, USA.
Christopher L Williams
Linda J Guynn
Michael J Benedik
Steven R Blanke
University of Houston · US

Funding

DRUG DESIGN FOR TREATING OPPORTUNISTIC INFECTION IN AIDSR01AI046340 · NIAID · UNIVERSITY OF HOUSTON · PI KRAUSE, KURT L. · 1999 to 2003
$2.0M
NIAID NIH HHS AI46340-03NIAID NIH HHS R01 AI046340
6 · The paper itself

Abstract

Serratia marcescens culture filtrates have been reported to be cytotoxic to mammalian cells. Using biochemical and genetic approaches, we have identified a major source of this cytotoxic activity. Both heat and protease treatments abrogated the cytotoxicity of S. marcescens culture filtrates towards HeLa cells, suggesting the involvement of one or more protein factors. A screen for in vitro cytotoxic activity revealed that S. marcescens mutant strains that are deficient in production of a 56-kDa metalloprotease are significantly less cytotoxic to mammalian cells. Cytotoxicity was significantly reduced when culture filtrates prepared from wild-type strains were pretreated with either EDTA or 1,10-phenanthroline, which are potent inhibitors of the 56-kDa metalloprotease. Furthermore, cytotoxic activity was restored when the same culture filtrates were incubated with zinc divalent cations, which are essential for enzymatic activity of the 56-kDa metalloprotease. Finally, recombinant expression of the S. marcescens 56-kDa metalloprotease conferred a cytotoxic phenotype on the culture filtrates of a nonpathogenic Escherichia coli strain. Collectively, these data suggest that the 56-kDa metalloprotease contributes significantly to the in vitro cytotoxic activity commonly observed in S. marcescens culture filtrates.

Indexed as

Bacterial ToxinsCytotoxinsEscherichia coliHeLa CellsHumansMetalloendopeptidasesRecombinant ProteinsSerratia marcescensZincBacterial ToxinsCytotoxinsMetalloendopeptidasesmicrobial metalloproteinasesRecombinant ProteinsZinc

Identifiers

PMID11854191
PMCPMC127783
OpenAlexW2097191787

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.